Orexigen Therapeutics, Inc. (NASDAQ:OREX) stock surges as Mysimba gets European approval Print E-mail
By Marilyn Mullen   
Friday, 27 March 2015 13:49
Orexigen Therapeutics, Inc. (NASDAQ:OREX) has confirmed that its weight-loss drug Mysimba  has been approved by European Commission which can be used with a low-calorie diet as well as increased physical activity for patients who want lose weight.
Read more...
 
Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) gets US Patent for its unique Kidney Cancer Test Print E-mail
By William Kent   
Thursday, 26 March 2015 15:27
Shares of Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) jumped 8% to $3.03 on moderate volume on Thursday after the company announced the new patent.
Read more...
 
Avalanche Biotechnologies Inc(NASDAQ:AAVL) Falls Over 4% Despite exclusive license agreement Print E-mail
By Josh Gee   
Wednesday, 25 March 2015 14:29
Avalanche Biotechnologies Inc. (NASDAQ:AAVL) shares slid 4% despite the company has announced that it has entered into an exclusive license agreement with University of Washington in Seattle for developing products based on Avalanche's proprietary Ocular BioFactory" Platform.
Read more...
 
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Slide After VX-661 Data Print E-mail
By Josh Gee   
Monday, 23 March 2015 13:53
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)’s shares fell 5.81 (-4.44%) to $125.19 after the company reported data of a 12-week Phase 2 study studying VX-661.
Read more...
 
Biogen Idec Inc (NASDAQ:BIIB) stock surges on news of Alzheimer drug Print E-mail
By William Kent   
Friday, 20 March 2015 17:22
Biogen Idec Inc. (NASDAQ:BIIB) shares surged by 10.8% in morning session briefly due to high volume after giving an update about its keenly tracked Alzheimer's disease drug candidate aducanumab.
Read more...
 
Organovo Holdings Inc (NYSEMKT:ONVO) Jumps 4% On Business Update Print E-mail
By William Kent   
Friday, 13 March 2015 15:42
Organovo Holdings Inc (NYSEMKT:ONVO)’s shares climbed up 4% to $4.60 following the company updated about its business.
Read more...
 
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Plunged 21% On Surprised News Of Delay in Application Print E-mail
By Marilyn Mullen   
Thursday, 12 March 2015 13:33
Shares of ACADIA Pharmaceuticals Inc.(NASDAQ:ACAD) tumbled 21% in Thursday’s session on hefty volume after the company surprised its shareholders by announcing that it will delay the
New Drug Application for its experimental Parkinson's disease psychosis drug nuplazid (pimavanserin) from this quarter to sometime in the

Error. Page cannot be displayed. Please contact your service provider for more details. (19)

2nd half of the
year.
Read more...
 
Second Sight Medical Products Inc. (NASDAQ:EYES) Gains 17% on implant progress Print E-mail
By Marilyn Mullen   
Tuesday, 24 February 2015 11:14
Shares of Second Sight Medical Products Inc. (NASDAQ:EYES) soared 17% to $9.92 on hefty volume in early session on Tuesday.
Read more...
 
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Surges 39% On Agreement with Bristol-Myers Squibb Print E-mail
By David Fowler   
Monday, 23 February 2015 11:57
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) jumped as much as 39% to $3.53 in Monday’s session on hefty volume of 8.80 million shares 28X its average volume.
Read more...
 
Celsion Corporation (NASDAQ:CLSN) Jumps 13% On Update of GEN-1 Print E-mail
By Marilyn Mullen   
Friday, 20 February 2015 14:52
Shares of thinly-traded nano cap Celsion Corporation (NASDAQ:CLSN) jumped almost 13% to $3.16 on heavy volume in response to its update on its advancement of GEN-1, its DNA-based immunotherapy, for the front-line treatment of advanced platinum-resistant and recurring ovarian cancer.
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 8 of 12

Newsletter

BMR:1